Publicaciones en las que colabora con María Dolores Lozano Escario (6)

2011

  1. Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance

    Clinical Cancer Research, Vol. 17, Núm. 12, pp. 4155-4166

2010

  1. TGFBI expression is associated with a better response to chemotherapy in NSCLC

    Molecular Cancer, Vol. 9

2004

  1. ERK 1/2 is activated in non-small-cell lung cancer and associated with advanced tumours

    British Journal of Cancer, Vol. 90, Núm. 5, pp. 1047-1052

  2. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients

    Clinical Cancer Research, Vol. 10, Núm. 11, pp. 3639-3649

  3. αCP-4, encoded by a putative tumor suppressor gene at 3p21, but not its alternative splice variant αCP-4a, is underexpressed in lung cancer

    Cancer Research, Vol. 64, Núm. 12, pp. 4171-4179

2003

  1. Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer

    Lung Cancer, Vol. 41, Núm. 2, pp. 131-143